Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice

Carcinogenesis

Volumn 29, Issue 8, 2008, Pages 1648-1654

  Leung, Wai K ^a   Wu, Kai Chun ^b   Wong, Christine Y P ^a   Cheng, Alfred S L ^a   Ching, Arthur K K ^a   Chan, Anthony W H ^a   Chong, Wilson W S ^a   Go, Minnie Y Y ^a   Yu, Jun ^a   To, Ka Fai ^a   Wang, Xin ^b   Chui, Y l ^a   Fan, D M ^b   Sung, Joseph J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; DRINKING WATER; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHYLNITROSOUREA; PROSTAGLANDIN E2; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL KINETICS; CHEMICAL CARCINOGENESIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; GASTRITIS; GENE CONSTRUCT; GENE OVEREXPRESSION; HIGH SODIUM INTAKE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TRANSGENE; WILD TYPE;

ANIMALS; APOPTOSIS; CELL DIVISION; CYCLOOXYGENASE 2; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLNITROSOUREA; MICE; MICE, TRANSGENIC; OVIDUCTS; PSEUDOPREGNANCY; SODIUM CHLORIDE, DIETARY; STOMACH NEOPLASMS;

EID: 49649116457     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn156     Document Type: Article

References (32)

1. Parkin,D.M. et al. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74-108.
2. Sung,J.J.Y. et al. (2000) Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study. Gastroenterology, 119, 7-14.
3. Wong,B.C. et al. (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA, 291, 187-194.
4. Leung,W.K. et al. (2004) Factors predicting progression of gastric intestinal metaplasia: Results of a randomised trial on Helicobacter pylori eradication. Gut, 53, 1244-1249.
5. You,W.C. et al. (2006) Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl Cancer Inst., 98, 974-983.
6. Wang,W.H. et al. (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: A systematic review and meta-analysis. J. Natl Cancer Inst., 95, 1784-1791.
7. Dannenberg,A.J. et al. (2003) Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise. Cancer Cell, 4, 431-436.
8. Hu,P.J. et al. (2004) Chemoprevention of gastric cancer by celecoxib in rats. Gut, 53, 195-200.
9. Yu,J. et al. (2005) Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: Implications on chemoprevention. World J. Gastroenterol., 11, 41-45.
10. Sung,J.J. et al. (2000) Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am. J. Pathol., 157, 729-735.
11. Chan,F.K. et al. (2001) Expression and cellular localization of COX-1 and -2 in Helicobacter pylori gastritis. Aliment. Pharmacol. Ther., 15, 187-193.
12. Oshima,H. et al. (2004) Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenicmice. EMBO J., 23, 1669-1678.
13. Shikata,K. et al. (2006) A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int. J. Cancer, 119, 196-201.
14. Fox,J.G. et al. (1999) High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res., 59, 4823-4828.
15. Takahashi,M. et al. (1994) Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with Nmethyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis, 15 1429-1432.
16. Kato,S. et al. (2006) High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int. J. Cancer, 119, 1558-1566.
17. Nakamura,Y. et al. (2002) Helicobacter pylori does not promote N-methyl-N-nitrosourea-induced gastric carcinogenesis in SPF C57BL/6 mice. Jpn. J. Cancer Res., 93, 111-116.
18. Han,S.U. et al. (2002) Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J. Gastroenterol. Hepatol., 17, 253-261.
19. Dixon,M.F. et al. (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol., 20, 1161-1181.
20. WHO. (2003) Diet, nutrition and the prevention of chronic diseases. World Health Organ. Tech. Rep. Ser., 916, i-viii1-149.
21. Rogers,A.B. et al. (2005) Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res., 65, 10709-10715.
22. El-Omar,E.M. et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193-1201.
23. Machado,J.C. et al. (2003) A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology, 125, 364-371.
24. Figueiredo,C. et al. (2002) Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J. Natl Cancer Inst., 94, 1680-1687.
25. Rad,R. et al. (2003) Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 188, 272-281.
26. Hou,L. et al. (2007) Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis, 28 118-123.
27. Lu,W. et al. (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis, 26, 631-636.
28. Zeng,Z.R. et al. (2003) Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut, 52, 1684-1689.
29. Leung,W.K. et al. (2006) H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am. J. Gastroenterol., 101 714-720.
30. Jackson,C.B. et al. (2007) Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J. Pathol. 213, 140-151.
31. Lin,M.T. et al. (2007) IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int. J. Cancer, 120, 2600-2608.
32. Lundin,B.S. et al. (2007) The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10. Clin. Immunol., 125, 205-213.